Repository logo
 
Publication

Side-effects of analgesic kyotorphin derivatives : advantages over clinical opioid drugs

dc.contributor.authorRibeiro, Marta M. B.
dc.contributor.authorSantos, Sónia Sá
dc.contributor.authorSousa, David S. C.
dc.contributor.authorOliveira, Margarida
dc.contributor.authorSantos, Sara M.
dc.contributor.authorHeras, Montserrat
dc.contributor.authorBardaji, Eduard
dc.contributor.authorTavares, Isaura
dc.contributor.authorCastanho, Miguel A. R. B.
dc.date.accessioned2014-03-05T16:55:58Z
dc.date.available2014-03-05T16:55:58Z
dc.date.issued2013
dc.description© Springer-Verlag 2013eng
dc.description.abstractThe adverse side-effects associated with opioid administration restrain their use as analgesic drugs and call for new solutions to treat pain. Two kyotorphin derivatives, kyotorphin-amide (KTP–NH2) and ibuprofen–KTP–NH2 (IbKTP–NH2) are promising alternatives to opioids: they trigger analgesia via an indirect opioid mechanism and are highly effective in several pain models following systemic delivery. In vivo side-effects of KTP–NH2 and IbKTP–NH2 are, however, unknown and were evaluated in the present study using male adult Wistar rats. For comparison purposes, morphine and tramadol, two clinically relevant opioids, were also studied. Results showed that KTP-derivatives do not cause constipation after systemic administration, in contrast to morphine. Also, no alterations were observed in blood pressure or in food and water intake, which were only affected by tramadol. A reduction in micturition was detected after KTP–NH2 or tramadol administrations. A moderate locomotion decline was detected after IbKTP–NH2-treatment. The side-effect profile of KTP–NH2 and IbKTP–NH2 support the existence of opioid-based mechanisms in their analgesic actions. The conjugation of a strong analgesic activity with the absence of the major side-effects associated to opioids highlights the potential of both KTP–NH2 and IbKTP–NH2 as advantageous alternatives over current opioids.eng
dc.description.sponsorshipFundação para a Ciência e Tecnologia (Portugal) is acknowledged for funding: SFRH/BD/42158/2007 fellowship to M. Ribeiro and SFRH/BI/51213/2010 fellowship (for doctorate) to S. Sá Santos associated to Marie Curie IAPP. Marie Curie Industry-Academia Partnerships and Pathways (European Commission) is also acknowledged for funding (FP7-PEOPLE-2007-3-1-IAPP. Project 230654). The authors acknowledge and appreciate the financial support received from Faculdade de Medicina da Universidade de Lisboa and Fundação Amadeu Dias, Portugal (Project No. 2010029)eng
dc.identifier.citationAmino Acids (2013) 45:171–178eng
dc.identifier.issn0939-4451
dc.identifier.urihttp://dx.doi.org/10.1007/s00726-013-1484-2
dc.identifier.urihttp://hdl.handle.net/10451/10689
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherSpringereng
dc.relation.publisherversionThe definitive version is available at http://www.springer.com/eng
dc.subjectKyotorphineng
dc.subjectAnalgesic peptideseng
dc.subjectOpioidseng
dc.subjectSide-effectseng
dc.subjectMorphineeng
dc.subjectConstipationeng
dc.titleSide-effects of analgesic kyotorphin derivatives : advantages over clinical opioid drugseng
dc.typejournal article
dspace.entity.typePublication
oaire.awardURIinfo:eu-repo/grantAgreement/EC/FP7/230654
oaire.citation.endPage178por
oaire.citation.startPage171por
oaire.citation.titleAmino Acidseng
oaire.citation.volume45por
oaire.fundingStreamFP7
project.funder.identifierhttp://doi.org/10.13039/501100008530
project.funder.nameEuropean Commission
rcaap.rightsclosedAccesspor
rcaap.typearticlepor
relation.isProjectOfPublicationc0d24731-bdbf-43ff-a9ae-fe6ad95c2622
relation.isProjectOfPublication.latestForDiscoveryc0d24731-bdbf-43ff-a9ae-fe6ad95c2622

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Amino_Acids_KTP.pdf
Size:
344.12 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.2 KB
Format:
Item-specific license agreed upon to submission
Description: